Transfer learning at Northwestern University accelerates the development of novel disease treatments.
The article discusses how technological advancements in gene sequencing and computational power have enabled the emergence of a new study from Northwestern University. Researchers at Northwestern have developed an innovative approach using artificial intelligence (AI) to analyze publicly available data and predict gene combinations that can transform cell behavior or restore diseased cells to a healthy state. The study, set to be published in the Proceedings of the National Academy of Sciences, highlights the potential of AI in revolutionizing disease treatments.
Since the human genome project's completion two decades ago, scientists have been intrigued by how thousands of genes interact to regulate diverse cell types in the human body. Through trial and error, researchers have shown that manipulating a few key genes can reprogram cell types. With the decreasing costs of gene sequencing and gene expression measurement, an abundance of bioinformatic data has been amassed, allowing for the possibility of designing gene manipulations to elicit specific cell behaviors.
The ability to control cell behavior opens doors for regenerating tissues and reversing cancer cells' transformation. Injuries from conditions like strokes, arthritis, and multiple sclerosis affect millions annually, while cancer remains a global health burden with significant economic costs. As current treatments have limitations, there is a pressing need for more effective therapies, underscoring the importance of identifying molecular interventions from high-throughput data.
Northwestern's AI model learns how gene expression influences cell behavior using available data and then applies this knowledge to reprogramming cells. The approach simplifies the complex network of gene interactions by representing them as eigengenes, which reflect how genes work together. By quantitatively capturing gene expression changes using eigengenes, the model can predict which gene perturbations will induce desired cell transitions.
The innovative aspect of this study lies in its ability to predict gene combinations computationally, avoiding the need to test all possible combinations experimentally. The approach's optimization algorithm allows it to assess numerous combinations efficiently, even as the number of combinations grows exponentially. Additionally, the model's additive combination of gene responses enables generalization across different cell types, making it versatile for various biomedical conditions.
The AI-powered approach serves as a flexible platform adaptable to different diseases, offering a way to address cell dysfunction in conditions like cancer, diabetes, and autoimmune diseases. Its capacity to integrate specific patient data and rapidly contextualize it with vast gene expression archives makes it a valuable tool for interpreting data and predicting gene behavior in normal and diseased cells.
In conclusion, this research from Northwestern University showcases the potential of transfer learning and AI in designing novel strategies for disease treatment and cell reprogramming. By leveraging publicly available data and computational power, the study represents a significant step towards personalized and effective biomedical interventions.
Source: https://www.eurekalert.org/news-releases/1036483
Since the human genome project's completion two decades ago, scientists have been intrigued by how thousands of genes interact to regulate diverse cell types in the human body. Through trial and error, researchers have shown that manipulating a few key genes can reprogram cell types. With the decreasing costs of gene sequencing and gene expression measurement, an abundance of bioinformatic data has been amassed, allowing for the possibility of designing gene manipulations to elicit specific cell behaviors.
The ability to control cell behavior opens doors for regenerating tissues and reversing cancer cells' transformation. Injuries from conditions like strokes, arthritis, and multiple sclerosis affect millions annually, while cancer remains a global health burden with significant economic costs. As current treatments have limitations, there is a pressing need for more effective therapies, underscoring the importance of identifying molecular interventions from high-throughput data.
Northwestern's AI model learns how gene expression influences cell behavior using available data and then applies this knowledge to reprogramming cells. The approach simplifies the complex network of gene interactions by representing them as eigengenes, which reflect how genes work together. By quantitatively capturing gene expression changes using eigengenes, the model can predict which gene perturbations will induce desired cell transitions.
The innovative aspect of this study lies in its ability to predict gene combinations computationally, avoiding the need to test all possible combinations experimentally. The approach's optimization algorithm allows it to assess numerous combinations efficiently, even as the number of combinations grows exponentially. Additionally, the model's additive combination of gene responses enables generalization across different cell types, making it versatile for various biomedical conditions.
The AI-powered approach serves as a flexible platform adaptable to different diseases, offering a way to address cell dysfunction in conditions like cancer, diabetes, and autoimmune diseases. Its capacity to integrate specific patient data and rapidly contextualize it with vast gene expression archives makes it a valuable tool for interpreting data and predicting gene behavior in normal and diseased cells.
In conclusion, this research from Northwestern University showcases the potential of transfer learning and AI in designing novel strategies for disease treatment and cell reprogramming. By leveraging publicly available data and computational power, the study represents a significant step towards personalized and effective biomedical interventions.
Source: https://www.eurekalert.org/news-releases/1036483
Comments
Post a Comment